GLP-1 Drugs Appear to Prevent Cancer, New Research Finds
(futurism.com)
1.
3.
Is the weight-loss drug boom moving past the Ozempic era?
(feeds.feedburner.com)
4.
The biggest shift in the weight-loss drug boom may not be Ozempic anymore
(feeds.feedburner.com)
6.
Wegovy Maker Novo Nordisk Strikes Deal With OpenAI to Speed Up Drug Discovery
(feeds.content.dowjones.io)
7.
8.
A new weight-loss pill is here, and it could reshape the GLP-1 market
(feeds.feedburner.com)
9.
FDA Approves Eli Lilly’s GLP-1 Pill
(wired.com)
10.
FDA Approves Eli Lilly's GLP-1 Pill
(wired.com)
11.
Wegovy’s new pricing could save you $1,200—but it’s not for everyone
(feeds.feedburner.com)
12.
Ro CEO on the next phase of the Ozempic boom
(feeds.feedburner.com)
13.
14.
FDA approves higher-dose version of Wegovy shots
(feeds.feedburner.com)
15.
Can weight-loss pills replace injectables? What the science says
(feeds.nature.com)
16.
Hims & Hers is scrapping its plan for a knockoff Wegovy weight-loss pill. Here’s why
(feeds.feedburner.com)
17.
Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war
(news.ycombinator.com)